Concepedia

Claire Rooney

CR

30

Publications

2.3K

Citations

22

H-Index

1996

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

Leicester Royal Infirmary

University of Liverpool

Royal Surrey County Hospital

Claire Rooney is an author at AstraZeneca (United Kingdom) specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1996–2024

30

Publications

30

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

Paul R. Gavine, Lorraine Mooney, Elaine Kilgour et al. · Cancer Research · 2012 · 491 citations

, , +16

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 259 citations · Full text

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS

Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson et al. · Science Translational Medicine · 2017 · 175 citations

A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

Paul K. Paik, Ronglai Shen, Michael F. Berger et al. · Clinical Cancer Research · 2017 · 144 citations · Full text

An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade

Lynda Vuong, Eleni Kouverianou, Claire Rooney et al. · Cancer Research · 2019 · 138 citations · Full text

Rows per page

1–5 of 30